Abbvie
- All
- News
-
Oxford To Study Anti-Inflammatory Drug As Covid Treatment
Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Glenmark Gets FDA Nod to Sell Blood Pressure Drug
Glenmark Pharmaceuticals on Thursday announced receipt of approval from the US Food and Drug Administration (FDA) to sell its generic version of AbbVie Inc's blood pressure drug Tarka in the American market.
-
Cadila Launches First Cheaper Copy of World's Top-Selling Drug
Drug maker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price.
-
Hundreds of Firms Join Global Hunt for Copycat Biotech Drugs
Biotech medicines - made from proteins and other large molecules - account for six of the 10 biggest-selling drugs in the world today, led by AbbVie's $12 billion-a-year rheumatoid arthritis injection Humira.
-
Google's Calico Partners AbbVie to Battle Age-Related Illnesses
The companies will combine strengths to discover, develop and bring to market new therapies.
-
Aurobindo Gets US Regulator Nod For Mental Illness Drug
The company has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Divalproex Sodium Extended-release tablets in strengths of 250mg and 500mg, Aurobindo Pharma said in a statement today.
-
Lupin launches cholesterol reduction drug in US market
Lupin Ltd on Friday launched its generic version of Niaspan extended release tablets used in reducing cholesterol in the US market.
-
Dr Reddy's sued for 'infringement' of patent
The US drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.
-
Oxford To Study Anti-Inflammatory Drug As Covid Treatment
Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Glenmark Gets FDA Nod to Sell Blood Pressure Drug
Glenmark Pharmaceuticals on Thursday announced receipt of approval from the US Food and Drug Administration (FDA) to sell its generic version of AbbVie Inc's blood pressure drug Tarka in the American market.
-
Cadila Launches First Cheaper Copy of World's Top-Selling Drug
Drug maker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price.
-
Hundreds of Firms Join Global Hunt for Copycat Biotech Drugs
Biotech medicines - made from proteins and other large molecules - account for six of the 10 biggest-selling drugs in the world today, led by AbbVie's $12 billion-a-year rheumatoid arthritis injection Humira.
-
Google's Calico Partners AbbVie to Battle Age-Related Illnesses
The companies will combine strengths to discover, develop and bring to market new therapies.
-
Aurobindo Gets US Regulator Nod For Mental Illness Drug
The company has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Divalproex Sodium Extended-release tablets in strengths of 250mg and 500mg, Aurobindo Pharma said in a statement today.
-
Lupin launches cholesterol reduction drug in US market
Lupin Ltd on Friday launched its generic version of Niaspan extended release tablets used in reducing cholesterol in the US market.
-
Dr Reddy's sued for 'infringement' of patent
The US drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.
